°³¶ËÀ̳׿¡¼ ÆÇ¸ÅµÈ "¼Òµ¿¹° ÇǺÎÇÐ ½ÃÅ©¸´" Á¤°¡ 80,000¿ø Æò±ÕÇÒÀΰ¡
|
|
|
Á¦ 1Æí ÃÑ·Ð 1. ÇǺÎÀÇ ±¸Á¶¿Í ±â´É Karen L. Campbell, DVM, MS, DACVIM, DACVD / Carol A. Lichtensteiger, DVM, PhD, DACVP 2. ÇǺÎÇÐ ¿ë¾î Karen L. Campbell, DVM, MS, DACVIM, DACVD / Carol A. Lichtensteiger, DVM, PhD, DACVP 3. ÇǺÎÇÐÀÇ Áø´Ü ±â¹ý Paul Bloom, DVM, DABVP, DACVD 4. ÇǺλý°Ë ¾È³»¼ : º´¸®ÇÐÀÚÀÇ °üÁ¡¿¡¼ Robert W. Dunstan, DVM, MS, DACVP / Elizabeth A. Mauldin, DVM, DACVP, DACVD / Gary M. Davenport, PhD Kelly / M. Credille, DVM, PhD, DACVP
Á¦ 2Æí ÇǺΰú Ä¡·á 5. °¡·Á¿òÁõ¿¡ ´ëÇÑ °ü¸® Paul Bloom, DVM, DABVP, DACVP 6. Ç×±ÕÁ¦ Ä¡·á Jan A. Hall, BVM&S, MS, MRCVS, DACVD 7. ÇǺÎÇп¡¼ÀÇ ±¸ÃæÁ¦ Robert Kennis, DVM, DACVD 8. ¸é¿ªº¸°Á¦ Ä¡·á(immunoadjuvant therapy) Karen L. Campbell, DVM, MS, DACVIM, DACVD 9. ±¹¼ÒÀû Ä¡·áÀÇ ¿ø¸® Randall C. Thomas, DVM, DACVD 10. ÇǺÎÇп¡¼ÀÇ ·¹ÀÌÀú Mona Boord, DVM, DACVD
Á¦ 3Æí ¼±ÃµÀû ÀÌ»ó 11. °¢È ÀÌ»ó Karen A. Kuhl, DVM, DACVD 12. Åаú ÅÐ ¼ºÀåÀÇ ÀÌ»ó Daniel O. Morris, DVM, DACVD 13. Äݶó°Õ°ú ¿¤¶ó½ºÆ¾ÀÇ ¹®Á¦ Jennifer L. Matousek, DVM, MS, DACVD 14. ¼±ÃµÀûÀÎ ¼öÆ÷¼º Áúȯ Christine A. Rees, DVM, DACVD 15. ¿©·¯ °¡Áö ¼±ÃµÀû ȤÀº À¯ÀüÀû Áúȯ Jennifer L. Matousek, DVM, MS, DACVD
Á¦ 4Æí ±â»ýÃ漺 ÇǺÎÁúȯ 16. ÀýÁöµ¿¹° ±â»ýÃæ Robert Kennis, DVM, DACVD 17. °ïÃæ Cecilia A. Friberg, DVM, DACVD 18. ¿¬Ã漺 ÇǺκ´(Helminth dermatoses) Randall C. Thomas, DVM, DACVD
Á¦ 5Æí °¨¿°¼º ÇǺÎÁúȯ 19. ¼¼±Õ¼º °¨¿° Jennifer L. Matousek, DVM, MS, DACVD 20. Ç¥À缺 Áø±Õ °¨¿° Karen A. Moriello, DVM, DACVD 21. ½ÉÀ缺 Áø±Õ °¨¿° Karen L. Campbell, DVM, MS, DACVIM, DACVD 22. Pythiosis¿Í Lagenidiosis Rosanna Marsella, DVM, DACVD 23. ±âŸ °¨¿°Áõ Jennifer L. Matousek, DVM, MS, DACVD
Á¦ 6Æí ¿°Áõ¼º ÇǺÎÁúȯ 24. ¾ÆÅäÇÇ Pascal Prelaud, DV, DECVD 25. À½½Ä °ú¹ÎÁõ Stephanie R. Bruner, DVM, DACVD 26. Á¢Ã˼º °ú¹Î¹ÝÀÀ(contact hypersensitivity) Rosanna Marsella, DVM, DACVD 27. º·è ¾Ë·¯Áö ÇǺο° Diane E. Bevier, DVM, DACVD 28. ¼Ó¸³(Á¼½Ò)¼º ÇǺο° Diane E. Bevier, DVM, DACVD 29. °í¾çÀÌ È£»ê±¸¼º À°¾ÆÁ¾ º¹ÇÕü Christine A. Rees, DVM, DACVD 30. °³ È£»ê±¸¼º Á¾±âÁõ Dennis W. Crow, DVM, DACVD 31. Ư¹ß¼º ¹«±Õ¼º À°¾ÆÁ¾°ú ³ó¼º À°¾ÆÁ¾ ÁõÈıº Dennis W. Crow, DVM, DACVD 32. ¸é¿ª¸Å°³¼º ÇǺΠÁúȯ Sheila Torres, DVM, MS, PhD, DACVD 33. ´ÙÇüÈ«¹Ý°ú µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ Jan A. Hall, BVM&S, MS, MRCVS, DACVD 34. Áö¹æÃþ¿°(Panniculitis) Adam P. Patterson, DVM 35. Ç÷°ü¿°°ú Ç÷°üº´Áõ Daniel O. Morris, DVM, DACVD
Á¦ 7Æí ÇǺμҰßÀ» ³ªÅ¸³»´Â ³»ºÐºñ¿Í ´ë»ç¼º Áúȯ 36. °©»ó¼± ±â´ÉÀÌ»ó Manon Paradis, DVM, MVSc, DACVD 37. ºÎ½Å ±â´ÉÀÌ»ó Karen L. Campbell, DVM, MS, DACVIM, DACVD 38. ¼º È£¸£¸ó ÇǺÎÁúȯ Linda A. Frank, MS, DVM, DACVD 39. ±âŸ È£¸£¸ó ¹ÝÀÀ¼º Å»¸ðÁõ Manon Paradis, DVM, MVSc, DACVD 40. ´ë»ç¼º ¿ÜÇÇ ±«»çÁõ Stephanie R. Bruner, DVM, ACVD 41. ºÎÁ¾¾ç ÇǺΠÁúȯ Jennifer L. Matousek, DVM, MS, DACVD 42. ¾Æ¿¬(zinc) °ü·Ã¼º ÇǺÎÁõ Rod A.W. Rosychuk, DVM, DACVIM
Á¦ 8Æí ´Ù¾çÇÑ ¿øÀÎÀÇ ÇǺÎÁúȯ 43. ȯ°æ¼º ÇǺÎÁúȯ Rod A.W. Rosychuk, DVM, DACVIM 44. ½ÉÀμº ÇǺÎÁúȯ Adam P. Patterson, DVM 45. ¹ßÅé°ú ¹ßÅé ±âÀúºÎÀÇ Áúȯ John C. Angus, DVM, DACVD 46. Ç×¹®ÁÖÀ§ ´©°ü Áúȯ Steven L. Marks, BVSc, MS, MRCVS, DACVIM 47. ¾È°Ë¿° Ralph E. Hamor, DVM, MS, DACVO 48. »ö¼ÒÀÌ»ó Laura B. Stokking, PhD, DVM / Karen L. Campbell, DVM, MS, DACVIM, DACVD 49. ±ÍÀÇ Áúȯ John C. Angus, DVM, DACVD
Á¦ 9Æí ÇǺÎÁ¾¾ç 50. ºñ½Å»ý¹°¼º Á¾¾ç Thomas O. Manning, DVM, MS, DACVD Brett C. Wood, DVM 51. »óÇÇ ½Å»ý¹° Laura B. Stokking, PhD, DVM 52. ºÎ¼Ó±â ±â¿øÀÇ Á¾¾ç Thomas O. Manning, DVM, MS, DACVD / Brett C. Wood, DVM 53. °³¿Í °í¾çÀÌÀÇ ÇÇºÎ¿Í ÇÇÇÏÁ¶Á÷ÀÇ Áß°£¿± ½Å»ý¹° Áúȯ Timothy M. Fan, DVM, DACVIM 54. °³¿Í °í¾çÀÌÀÇ ÇǺΠºñ¸¸¼¼Æ÷ ½Å»ý¹° Timothy M. Fan, DVM, DACVIM 55. ¸²ÇÁ Á¶Á÷±¸¼º Á¾¾ç John C. Angus, DVM, DACVD / Louis-Philippe de Lorimier, DVM, DACVM 56. ¸á¶ó´Ñ ¼¼Æ÷ Á¾¾ç Laura B. Stokking, PhD, DVM 57. ¿©·¯ °¡Áö Á¾·ùÀÇ ÇǺÎÁ¾¾ç Brett C. Wood, DVM / Thomas O. Manning, DVM, MS, DACVD
»öÀÎ
|
|
|
|
|